COCP Cocrystal Pharma, Inc.
$0.98▲ +0.93%
Healthcare
Other
After hours
$1.00▲ +1.94%
Oct 27, 5:13 PM ET
Volume 15.4K
Avg Volume (10D) 45.9K
Key Metrics & Fundamentals
Market Cap
$18.90M
P/E Ratio
–
Div Yield
0.00%
52W Range
0.76 - 2.03
% vs 50 MA
-11.61%
% vs 200 MA
-11.13%
RSI-14
40.3
MACD Histogram
-0.0100
Beta (1Y vs SPY)
1.56
Free Cash Flow
-$2.52M
Gross Rev
$105,000
Gross Profit
$105,000
EBITDA
-$3.18M
COGS
–
Operating Exp
$3.29M
Operating Income
-$3.18M
EBIT
-$3.18M
Pretax Income
-$3.16M
Net Income
-$3.16M
EPS (Diluted)
-0.23
Price & Volume History
Loading chart…
Recent News
A norovirus breakthrough?; another women’s healthtech haul
Pharma Voice · Sep 18, 2026 9:48 AM ET
Cocrystal Pharma’s new CEO hopes to crack the norovirus code
Pharma Voice · Sep 15, 2026 8:56 AM ET
Cocrystal Pharma Announces Last Subject Dosed in Phase 1b Human Challenge Study Evaluating CDI-988 for Norovirus Prevention and Treatment
GlobeNewswire · Sep 9, 2026 7:00 AM ET
Cocrystal Pharma: The Strategic Reset Investors May Be Missing
Exec Edge · Aug 31, 2026 11:39 AM ET
COCP: $5 Million Private Placement with OPKO Health
Zacks Small Cap Research · Aug 20, 2026 7:20 AM ET
Cocrystal Pharma Appoints Carol Brosgart, MD to its Board of Directors
GlobeNewswire · Aug 17, 2026 11:17 AM ET
Cocrystal Pharma Announces $5 Million Private Placement with OPKO Health
GlobeNewswire · Aug 3, 2026 7:00 AM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See COCP's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.